Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Austria Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20063
20072
20082
20091
20101
20111
20123
20131
20142
20164
20174
20183
20193
20201
20212
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Active, not recruiting5
Recruiting3
Approved for marketing1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Bristol-Myers Squibb4
Pfizer4
Exelixis3
Ipsen3
AIO-Studien-gGmbH2
Bayer2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Agenus Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell40
Kidney Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Neoplasms4
Carcinoma3
Colorectal Neoplasms2
Melanoma2
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.